I’m in a New York State of Sepsis

By
Original story posted on: December 9, 2019

Sepsis is a clinical diagnosis, and clinicians should be permitted to make the diagnosis appropriately.

When I step up onto my sepsis soapbox, people often refer to New York State and tell me how they are not allowed to accept Sepsis-3, pursuant to state regulation. Full disclosure: I hail from New York.

I’ve read the regulations. Here’s what they say regarding adult sepsis (from Volume C (Title 10); Chapter V; Subchapter A; Article 2; Section 405.4 (Sepsis Regulations: Guidance Document 405.4 (a)(4)):

  • Section 405.4 of Title 10 requires all New York State-licensed hospitals to “have in place evidence-based protocols for the early identification and treatment of patients with severe sepsis and septic shock.”
  • The medical staff “shall adopt, implement, periodically update, and submit to the New York Department of Health evidence-based protocols for the early recognition and treatment of patients with severe sepsis and septic shock (“sepsis protocols”) that are based on generally accepted standards of care (my bolding).”
  • Protocols must include:
    • A process for the screening and early recognition of patients with sepsis, severe sepsis, and septic shock
    • A process to identify individuals who should be treated according to the sepsis protocols (i.e., severe sepsis and septic shock), including exclusion criteria
    • Guidelines for hemodynamic support and early antibiotic administration

All of these sound reasonable. We all agree that reducing overall mortality is a worthy goal.

The devil is in the details when you read the New York Department of Health analysis of the outcomes of the Office of the Medical Director and the Office of Quality and Patient Safety (NYS Report on Sepsis Care Improvement Initiative: Hospital Quality Performance).

It says that “sepsis is a life-threatening condition that requires early detection and timely, appropriate interventions to improve the chances of survival and optimize outcomes for patients of all ages.” It defines sepsis as “a clinical syndrome in which patients have an infection that is accompanied by an extreme systemic response.” Contemplate this: is having a fever and a corresponding tachycardia an “extreme” systemic response?

It is true that “for the purposes of data collection,” they use Sepsis-2 definitions: sepsis is defined as confirmed or suspected infection accompanied by two systemic inflammatory response syndrome (SIRS) criteria; severe sepsis is defined as sepsis (as defined above), complicated by organ dysfunction; adult septic shock is defined as sepsis-induced hypotension persisting despite adequate IV fluid resuscitation and/or evidence of tissue hypoperfusion. However, their protocols only mandate treatment of severe sepsis and septic shock, just like SEP-1.

This report specifies on page 5 that they are using “the term ‘sepsis’ to indicate severe sepsis and septic shock.” Can we make this more confusing?! If you have three categories (i.e., sepsis, severe sepsis, and septic shock), it is completely unacceptable to use the term “sepsis” to only indicate severe sepsis and septic shock!

Their performance measures mirror SEP-1. In fact, they acknowledge that “the alignment with CMS SEP-1 measure was intended to reduce measure abstraction burden for hospitals, and to minimize the confusion resulting from the discrepancy between NYS and CMS sepsis measures.”

The report’s authors are scrutinizing the medical care of severe sepsis and septic shock patients. As in the Centers for Medicare & Medicaid Services’ (CMS’s) SEP-1, patients without organ dysfunction, even if they trigger general variable systemic inflammatory response syndrome (SIRS) (e.g., fever or hypothermia, tachycardia, tachypnea, abnormal WBC), as per their definition of sepsis, are not included in the measures. The statistics noted in their Sepsis Measure Summary Report only refer to the treatment of severe sepsis and septic shock.

In conclusion, “early detection” of sepsis, when defined as confirmed or presumed infection with two SIRS criteria, leads to nowhere in New York State, CMS, or anywhere else. There is no mandated treatment until the organ dysfunction threshold is crossed (i.e., severe sepsis). Organ dysfunction is where Sepsis-3 starts.

While folks maintain that treatment of “early sepsis” will save lives, there is no evidence that anyone is looking at outcomes of treatment of sepsis prior to the development of organ dysfunction. New York State is not. There is no “early sepsis” category in any sepsis schema.

Finally, the Sepsis Initiative Improvement report noted that on Nov. 14, 2018, the regulation was amended to “clarify that sepsis definitions…are for the purposes of hospital data collection and reporting and are not intended to direct clinical care (my italics for emphasis).” Sepsis is a clinical diagnosis, and clinicians should be permitted to make the diagnosis appropriately. There are no gold standard diagnostic criteria, not SIRS, not sequential organ failure assessment (SOFA).

I reiterate: sepsis is life-threatening organ dysfunction due to dysregulated systemic host response to infection (i.e., the condition formerly known as “severe sepsis). It should be treated aggressively to try to prevent mortality. If you are concerned a patient is developing sepsis, treat it aggressively. If no organ dysfunction ensues, the patient never developed sepsis. Maybe you averted it.

SIRS may be a harbinger of sepsis, but it is not a defining characteristic, nor a diagnostic criterion. Acknowledge it, address it, but do not rely on it to make the diagnosis of sepsis, severe sepsis, or septic shock, whether you live in New York or not.

Programming Note:

Listen to Dr. Erica Remer’s reports live on Talk Ten Tuesday every Tuesday, 10-10:30 a.m. EST.

Erica E. Remer, MD, FACEP, CCDS

Erica Remer, MD, FACEP, CCDS has a unique perspective as a practicing emergency physician for 25 years, with extensive coding, CDI, and ICD-10 expertise. She was a physician advisor of a large multi-hospital system for four years before transitioning to independent consulting in July 2016. Her passion is educating CDI specialists, coders, and healthcare providers with engaging, case-based presentations on documentation, CDI, and denials management topics. She has written numerous articles and serves as the co-host of Talk Ten Tuesdays, a weekly national podcast. Dr. Remer is a member of the ICD10monitor editorial board, the ACDIS Advisory Board, and the board of directors of the American College of Physician Advisors.

Related Stories

  • CPT/AMA Announces a New PPE code – But is it Payable?
    Some third-party payers have reimbursed and will continue to reimburse providers for this new CPT code; others won’t. The American Medical Association (AMA) published a new CPT® code on Sept. 8 that accounts for extra provisions to ensure patient and provider safety during a public health emergency (PHE).  The…
  • Official Coding Guidelines Provide Direction for Other Care Settings
    If a patient has COVID-19 and pneumonia, he or she should be admitted to a skilled nursing facility (SNF) at the hospital until the patient tests negative. There are frequent coding questions for non-acute care facilities posted in coding listservs.…
  • New Changes to the Official Coding and Reporting Guidelines for Diabetic Medications
    November is Diabetes Awareness Month. November is Diabetes Awareness Month, and it seems additionally appropriate to review diabetes when there is a focus on chronic diseases.     According to the World Health Organization (WHO), diabetes is a chronic disease that…